Request Trial
Taljat David / Shutterstock.com
9 September 2024NewsUnified Patent CourtMuireann Bolger

UPC delivers first 'imminent infringement' decision in biosimilar dispute

UPC clarifies that evidence must show that pre-launch preparations are complete for threat of imminent infringement to occur | Question remains over how the UPC will deal with the cumulative activities of several companies in a group | Court also broaches key cross-border question.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Unified Patent Court
Regeneron and CureVac: UPC ‘cannot be ignored’
4 November 2025   Growing clout, powerful remedies, and efficiency are making the UPC a game-changer in global litigation, according to LSPN Europe experts. Tom Phillips reports.
Unified Patent Court
Abbott v Sibio: A game-changer for UPC tech disputes
27 February 2025   The UPC Court of Appeal’s approach to delivering a preliminary injunction in a glucose sensor dispute has far-reaching effects, as Wouter Pors of Bird & Bird explains.
Unified Patent Court
'A very good decision’: Patent industry welcomes UPC in-house reps update
13 February 2025   Court of Appeal says in-house representatives can appear before the court | Patent attorneys with ‘administrative and financial powers’ or shares remain barred | Decision specific to Microsoft v Suinno Mobile & AI Technologies Licensing.


Editor's picks

SCOTUS shuts the door on Entresto ‘after-arising technology’ review
Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025

Editor's picks

Americas
SCOTUS shuts the door on Entresto ‘after-arising technology’ review
17 December 2025
Americas
Teva scrubs 200-plus Orange Book patents after FTC turns the screw
11 December 2025
Americas
US govt backs Hikma over ‘skinny label’ rules
9 December 2025
Big Pharma
The clinical trial dilemma: Navigating European practice
27 November 2025
Europe
Biotech cleared to make biosimilar of $6bn treatment after landmark ruling
25 November 2025
Americas
INTA votes in new 2026 president at Florida leadership meeting
20 November 2025

More features

Mental health in IP: ‘We have a clear picture of the problem’
From Edwards to Insulet: Three key medical device cases of 2025
Edwards v Meril: Behind the UPC’s landmark medtech showdown
5 ways the USPTO director is changing US innovation
EU unveils sweeping pharma, biotech, and medical device reforms
Mirum targets generics in quartet of suits over liver treatment
Hogan Lovells and Cadwalader strike historic deal to create $3.6bn firm
Edwards v Meril: 3 insights from the UPC Court of Appeal’s decision